29June

Rybelsus® approved in Japan for the treatment of type 2 diabetes ... Read more

18June

Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combination ... Read more

12June

Semaglutide 2.4 mg shows superior weight loss versus placebo in the phase 3 tria ... Read more

11June

Novo Nordisk to acquire Corvidia Therapeutics and expand presence in cardiovascu ... Read more

28July

Novo Nordisk A/S – Share repurchase programme ... Read more

20July

Novo Nordisk A/S – Share repurchase programme ... Read more

13July

Novo Nordisk A/S – Share repurchase programme ... Read more

06July

Novo Nordisk A/S – Share repurchase programme ... Read more

06August

Financial statement for the first six months of 2020,

01October

Silent period,

30October

Financial statement for the first nine months of 2020,

08March

Commerzbank Sector Conference , Frankfurt

 

 

 

Investors

Share information
 

SHARE Magazine


Get the latest SHARE Magazine

News for you as an investor

 

Corporate reporting

Annual General Meeting

Annual General Meeting and Shareholders' Meeting 2020 (UK & DK)

Private shareholders


Shareholder tools and systems for private investors

 

Investor materials

Contact Investor Relations

Sign-up: Company announcements


Sign up上海快3 and receive our company announcements

 

Financial results and events overview

安徽快3 福建快3 江苏快3 上海快3 江西快3 pk10怎么玩 北京赛车PK10计划 广东快乐十分 广东快乐十分 甘肃快3